SEC Form 5 · accession 0001511164-17-000406
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock (Free trading) | Dec 5, 2008 | A | 840,000 | $0.0008 | A | 840,000 | D | |
| INVO Bioscience Common Stock (Restricted) | Dec 5, 2008 | A | 24,661,473 | $0.0008 | A | 24,661,473 | D |
Table II — derivative securities
Remarks
On December 5, 2008, i acquired the above securities from INVO Bioscience Inc. which completed a reverse merger with Emy's Salsa AJI Distribution Company Inc. I should have reported to the SEC on a Form 3 all these acquired securities. I should also have reported Form 4 and 5 from 2009 to 2016. I apologize for not filing all these forms. I along with other Officers and Directors if INVO Bioscience (INVO) were unaware of the individual Form 3, 4 & 5 filing requirement. During the process of catching up with the Company's filings in 2017, we learned we needed to file our own individual forms. The corporate attorneys of INVO had discussions with the SEC concerning the absence of filing our individual Forms 3, 4 and 5 from INVO Bioscience's Officers and Directors. The Officers and Directors received guidance that it was permissible with the SEC for us to catch up by only filing a Form 5 in each of the years 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015 and 2016.